Tenaya Therapeutics Receives Nasdaq Delisting Notice, Expands Equity Incentive Plan
TNYA has more than doubled off its 52-week low of $0.36.
Summary
Tenaya Therapeutics received a Nasdaq delisting notice for failing to meet the minimum bid price, triggering a 180-day compliance period, and also increased its equity incentive plan shares.
Key Events · Legal and Risk Events · TNYA
-
Nasdaq Minimum Bid Price Deficiency
The company received a notice from Nasdaq on January 28, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days.
-
180-Day Compliance Period Initiated
Tenaya Therapeutics has until July 27, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of ten consecutive business days.
-
Equity Incentive Plan Expansion
The Board approved an amendment to the 2024 Inducement Equity Incentive Plan, increasing the shares reserved for issuance by an additional 2,161,000 shares, bringing the total to 3,361,000 shares.
Analysis · TNYA · Life Sciences
Tenaya Therapeutics, Inc. received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, initiating a 180-calendar day compliance period until July 27, 2026. This is a critical event, as failure to regain compliance could lead to delisting from the Nasdaq Global Select Market, significantly impacting the company's market visibility and investor confidence. Concurrently, the Board approved an amendment to the 2024 Inducement Equity Incentive Plan, increasing the shares reserved for issuance by an additional 2,161,000 shares. While intended to attract new talent, this represents a notable potential dilution at a time when the company faces significant listing challenges, adding to investor concerns.
At the time of this filing, TNYA was trading at $0.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $167.7M. The 52-week trading range was $0.36 to $2.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.